(Date:5/16/2008)...Scheduled for May 19 at 10:15 a.m. Eastern Time, ...e Biomedical,Corporation (TSX: RBM, OTCBB: RPBIF) ... Officer, is scheduled to present at the Rodman & ... Monday May 19th at 10:15 a.m.,EDT., A live web c...ompany,s,Web site at, http://www.responsebio.com/n...
(Date:5/16/2008)...eeds is more unemployed politicians - and economis... -- Although nearly all,voters place health care a... looming federal budgetary crunch means none of th... presidential candidates is likely to become,law a...er Bill Frist., Jousting with Princeton Universit...
(Date:5/16/2008)...RNewswire/ -- Huntsworth plc (LSE: HNT), "the Grou...ealthcare communications,group headquartered in Lo...respect to the Group,s performance in the first qu... The statement follows below., 15 May 2008, ... Interim Management Statement, ...
(Date:5/16/2008)...ds Focus on Millions of Children Still in Danger, ...r UNICEF and The,Advertising Council today announc...s of national public service announcements (PSAs) ...r, Nicole Ritchie, Joel Madden, David,Duchovny, Te...vors of the,Myanmar cyclone. The Ad Council is dis...
Breaking Medicine News(10 mins):Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3...ile teenagers have a greater resistance to alcohol...nskaya and other researchers studied the effects o... teenagers and adults. The rats - chosen because ...ics that of humans - were dosed with alcohol and t...
...ions regarding booze often finds thousands in the ...erson// in authority ever raising eyebrows until r...t estimates prove that over forty two thousand Rus...d to alcoholism. However a closer scrutiny has als...
...ystem to undertake greater activities related to s... and benchmarks for evaluating and monitoring such...of sport as an instrument that can bring people to...ting, Indian delegate Mufti Mohammed Sayeed said F...
...t six doctors of Indraprastha Apollo Hospital in ...e// for destruction of evidence related to Rahul M...-- Anupam Sibal, Prasad Rao, Awdesh Bansal, Mukund...Gupta. Six other staff of the hospital were also ...
Other Medicine News:Health News:Older People Get Worse Hangovers 2(Date:5/15/2008)..., N.J., May 15 /- Eisai Corporation o...16 clinical data abstracts about,compounds in the ...,preclinical oncology research have been accepted ... American Society of Clinical Oncology (ASCO),tak... A wide variety of abstracts on Eisai marketed pr...
(Date:5/15/2008)...n clinical data highlight safety profile of BSI-20...tumors -, BRISBANE, Calif., May 15 /...ceutical company developing novel cancer therapies...RP inhibitor, BSI-201, will,be presented at the 20...eting in Chicago., Findings will be presented fro...
(Date:5/15/2008)...tralia, May 15 /- Cytopia L...t for its upcoming oral,presentation on CYT997 at ... Clinical Oncology (ASCO) will be accessible to th...) from 9pm on Thursday 15 May (US EDT)., The oral...997, a novel,cytotoxic and vascular disrupting age...
(Date:5/15/2008)...uctions demonstrated in Blacks, Hispanics/Latinos,...ndividuals, PARSIPPANY, N.J., May 15 /PRNewswire/...a presented at the American Society of,Hypertensio...008) in New,Orleans demonstrated that the powerful...tan medoxomil) safely and effectively helped,patie...
Breaking Medicine Technology:Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7CardiacAssist Inc Announces Five New TandemHeart Centers of Excellence 17205 1CardiacAssist Inc Announces Five New TandemHeart Centers of Excellence 17205 2Beijing Genomics Institute adds AB SOLiD system to its next generation sequencing technologies 2958 1U S Patent Office Allows Significant New VNUS Patent 17202 1U S Patent Office Allows Significant New VNUS Patent 17202 2U S Patent Office Allows Significant New VNUS Patent 17202 3VisEn Medical Raises 245 0 Million in Expanded Series B Financing 17197 1VisEn Medical Raises 245 0 Million in Expanded Series B Financing 17197 2VisEn Medical Raises 245 0 Million in Expanded Series B Financing 17197 3...mdash; April 27, 2007 — SciClone,Pharmaceuti...,following abstracts have been accepted for the An...ncology in Chicago, Illinois on,June 1-5, 2007: , ...ter,Presentation ,A large first-line, randomized, ...T?1) plus Dacarbazine (DTIC) with or without,Inter...
...USINESS WIRE)--Apr 30, 2007 - CollaGenex,Pharmaceu...new,report in the May 2007 issue of the Journal of...o randomized phase III clinical trials,demonstrat...se,doxycycline (Oracea(R), 40-mg doxycycline, USP ...t has concluded these studies,establish the first ...
Other Medicine Technology:SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO 2Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea 2Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea 3Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea 4... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
Medicine Products: